FundCalibre's McDermott: Embracing an artificial reality

How AI can help – not hinder – investment processes

clock • 3 min read

Caroline Criado-Perez was on BBC Radio 2 a couple of weeks ago, talking about her book Invisible Women: Exposing Data Bias in a World Designed for Men

Caroline was pointing out that, while governments, companies and individuals rely on data to make all sorts of important decisions about healthcare, schools and insurance, in the majority of cases that data is fundamentally flawed.  Morgan Stanley retains best equity fund manager crown in FundCalibre index The world, she said, is largely built for men because the majority of data we collect is from, and used by, men. She gave a ream of consequences, such as the fact that women are more likely to be injured in a car accident because the seats have been built for men and cars tested ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot